Effects of oral and intravenous lipid load on Hepatitis C virus concentrations in serum and lipoprotein subfractions
Phase 1
- Conditions
- chronic hepatitis CTherapeutic area: Diseases [C] - Virus Diseases [C02]
- Registration Number
- EUCTR2011-002351-34-AT
- Lead Sponsor
- Medizinische Universitaet Wien, Univ.Klinik f.Innere Medizin III, Abteilung fuer Gastroenterologie und Hepatologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
30 adult patients with chronic hepatitis C, either untreated or nonresponders who have not received antiviral therapy within the last 6 months.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Patients with lipoprotein disorders
Patients with portocaval shunts (spontaneous or TIPS)
Patients on lipid lowering therapy
Known soy bean and nuts allergy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method